Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Salvage Therapy"" wg kryterium: Temat


Tytuł:
Salvage Treatment and Outcomes of Locally Advanced Cervical Cancer after Failed Concurrent Chemoradiation with or without Adjuvant Chemotherapy: Post Hoc Data Analysis from the ACTLACC Trial.
Autorzy:
Asakij T; Radiation Oncology Section, Lampang Cancer Hospital, Thailand.
Khunnarong J; Department of Obstetrics and Gynecology, Faculty of Medicine Vajira Hospital, Navamindradhiraj University, Thailand.
Tangjitgamol S; Women's Health Center, MedPark Hospital, Bangkok, Thailand.
Rongsriyam K; Division of Radiation Oncology, Department of Radiology, Faculty of Medicine Vajira Hospital, Navamindradhiraj University, Thailand.
Tharavichitkul E; Division of Radiation Oncology, Department of Radiology, Faculty of Medicine Chiang Mai University, Thailand.
Tovanabutra C; Radiation Oncology Section, Chonburi Cancer Hospital, Thailand.
Paengchit K; Gynecologic Oncology section, Lampang Cancer Hospital, Thailand.
Sukhaboon J; Radiation Oncology Section, Lopburi Cancer Hospital, Thailand.
Kridakara LCA; Radiation Oncology Section, Bhumibol Adulyadej Hospital, Thailand.
Atjimakul T; Department of Obstetrics and Gynecology, Prince of Songkla University, Thailand.
Pariyawateekul P; Obstetrics and Gynecology Section, Bhumibol Adulyadej Hospital, Thailand.
Tanprasert P; Obstetrics and Gynecology Section, Rajburi Hospital, Thailand.
Pokaż więcej
Źródło:
Asian Pacific journal of cancer prevention : APJCP [Asian Pac J Cancer Prev] 2022 Jul 01; Vol. 23 (7), pp. 2263-2269. Date of Electronic Publication: 2022 Jul 01.
Typ publikacji:
Journal Article
MeSH Terms:
Salvage Therapy*
Uterine Cervical Neoplasms*/pathology
Uterine Cervical Neoplasms*/therapy
Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Carboplatin/therapeutic use ; Chemoradiotherapy ; Chemotherapy, Adjuvant ; Cisplatin/therapeutic use ; Female ; Humans ; Paclitaxel/therapeutic use ; Randomized Controlled Trials as Topic ; Treatment Failure ; Treatment Outcome
Czasopismo naukowe
Tytuł:
ALK inhibition as a salvage therapy for a relapsed unclassifiable sarcomatous CNS tumor with EML4/ALK fusion in an infant.
Autorzy:
Holsten T; Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Bronsema A; Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Sturm D; Hopp Children's Cancer Center (KiTZ), Heidelberg, Germany Pediatric Glioma Research, Germany.; Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.; Department of Pediatric Oncology, Hematology & Immunology, Heidelberg University Hospital, Heidelberg, Germany.
Sahm F; Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany.; Department of Neuropathology, University Hospital Heidelberg and CCU Neuropathology, Heidelberg, Germany.
Rutkowski S; Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Schüller U; Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Research Institute Children's Cancer Center Hamburg, Hamburg, Germany.; Institute of Neuropathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Wößmann W; Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Kordes UR; Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Pokaż więcej
Źródło:
Pediatric blood & cancer [Pediatr Blood Cancer] 2022 Aug; Vol. 69 (8), pp. e29594. Date of Electronic Publication: 2022 Feb 23.
Typ publikacji:
Letter
MeSH Terms:
Lung Neoplasms*/pathology
Salvage Therapy*
Gene Fusion ; Humans ; Oncogene Proteins, Fusion/genetics ; Receptor Protein-Tyrosine Kinases/genetics
Opinia redakcyjna
Tytuł:
Moderate hypofractionation for salvage radiotherapy (HYPO-SRT) in patients with biochemical recurrence after prostatectomy: A cohort study with meta-analysis.
Autorzy:
Viani GA; Department of Medical Imagings, Hematology and ONCOLOGY of University of São Paulo (FMRP-USP), Member of Latin America Cooperative Oncology Group (LACOG), Radiotherapy Division, Brazil. Electronic address: .
Gouveia AG; Radiation Oncology Department - Américas Centro de Oncologia Integrado - Rio de Janeiro, Member of Latin America Cooperative Oncology Group (LACOG), Radiotherapy Division, Brazil.
Leite ETT; Radiation Oncology Department, Hospital Vila Nova Star. Instituto do Câncer do Estado de São Paulo - FMUSP, Brazil.
Moraes FY; Department of Oncology - Division of Radiation Oncology, Kingston General Hospital, Queen's University, Member of Latin America Cooperative Oncology Group (LACOG), Radiotherapy Division, Kingston, Canada.
Pokaż więcej
Źródło:
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2022 Jun; Vol. 171, pp. 7-13. Date of Electronic Publication: 2022 Mar 11.
Typ publikacji:
Journal Article; Meta-Analysis
MeSH Terms:
Neoplasm Recurrence, Local*/radiotherapy
Prostatic Neoplasms*/radiotherapy
Prostatic Neoplasms*/surgery
Radiation Dose Hypofractionation*
Salvage Therapy*
Cohort Studies ; Humans ; Male ; Prostate-Specific Antigen ; Prostatectomy ; Radiotherapy Dosage ; Retrospective Studies
Czasopismo naukowe
Tytuł:
Timing of Ga68-PSMA PETCT and patterns of recurrence after prostate radiotherapy: Implications for potential salvage.
Autorzy:
Maitre P; Department of Radiation Oncology, Tata Memorial Hospital and Advanced Centre for Treatment Research and Education in Cancer (ACTREC), Homi Bhabha National Institute (HBNI), Mumbai, India.
Sood S; Department of Radiation Oncology, Tata Memorial Hospital and Advanced Centre for Treatment Research and Education in Cancer (ACTREC), Homi Bhabha National Institute (HBNI), Mumbai, India.
Pathare P; Department of Radiation Oncology, Tata Memorial Hospital and Advanced Centre for Treatment Research and Education in Cancer (ACTREC), Homi Bhabha National Institute (HBNI), Mumbai, India.
Krishnatry R; Department of Radiation Oncology, Tata Memorial Hospital and Advanced Centre for Treatment Research and Education in Cancer (ACTREC), Homi Bhabha National Institute (HBNI), Mumbai, India.
Agrawal A; Department of Nuclear Medicine and Molecular Imaging, Tata Memorial Hospital and Advanced Centre for Treatment Research and Education in Cancer (ACTREC), Homi Bhabha National Institute (HBNI), Mumbai, India.
Rangarajan V; Department of Nuclear Medicine and Molecular Imaging, Tata Memorial Hospital and Advanced Centre for Treatment Research and Education in Cancer (ACTREC), Homi Bhabha National Institute (HBNI), Mumbai, India.
Murthy V; Department of Radiation Oncology, Tata Memorial Hospital and Advanced Centre for Treatment Research and Education in Cancer (ACTREC), Homi Bhabha National Institute (HBNI), Mumbai, India. Electronic address: .
Pokaż więcej
Źródło:
Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology [Radiother Oncol] 2022 Apr; Vol. 169, pp. 71-76. Date of Electronic Publication: 2022 Feb 18.
Typ publikacji:
Journal Article
MeSH Terms:
Prostatic Neoplasms*/diagnostic imaging
Prostatic Neoplasms*/pathology
Prostatic Neoplasms*/radiotherapy
Salvage Therapy*
Androgen Antagonists/therapeutic use ; Gallium Isotopes ; Gallium Radioisotopes ; Humans ; Male ; Neoplasm Recurrence, Local/diagnostic imaging ; Neoplasm Recurrence, Local/radiotherapy ; Oligopeptides ; Positron Emission Tomography Computed Tomography ; Prostate/pathology ; Prostate-Specific Antigen ; Prostatectomy ; Recurrence
Czasopismo naukowe
Tytuł:
External validation of nomograms for salvage radiotherapy after radical prostatectomy.
Autorzy:
Özman O; Department of Urology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
Veerman H; Department of Urology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Prostate Cancer Network, Amsterdam, The Netherlands.
Schaake E; Department of Radiation Oncology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
van der Poel H; Department of Urology, The Netherlands Cancer Institute, Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Prostate Cancer Network, Amsterdam, The Netherlands.
Pokaż więcej
Źródło:
BJU international [BJU Int] 2022 May; Vol. 129 (5), pp. 587-590. Date of Electronic Publication: 2022 Feb 06.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Nomograms*
Salvage Therapy*
Humans ; Male ; Neoplasm Recurrence, Local/surgery ; Prostate-Specific Antigen ; Prostatectomy
Czasopismo naukowe
Tytuł:
Regorafenib for Taiwanese patients with unresectable hepatocellular carcinoma after sorafenib failure: Impact of alpha-fetoprotein levels.
Autorzy:
Hsu PY; Graduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Cheng TS; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Chuang SC; Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Chang WT; Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Liang PC; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Hsu CT; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Wei YJ; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.; Department of Internal Medicine, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Jang TY; Graduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Yeh ML; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.; School of Medicine and Hepatitis Research Center, College of Medicine, and Center for Liquid Biopsy and Cohort Research and Center for Cancer Research, Kaohsiung Medical University, Kaohsiung, Taiwan.
Huang CI; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.; School of Medicine and Hepatitis Research Center, College of Medicine, and Center for Liquid Biopsy and Cohort Research and Center for Cancer Research, Kaohsiung Medical University, Kaohsiung, Taiwan.
Lin YH; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Wang CW; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Hsieh MY; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.; Department of Internal Medicine, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Hou NJ; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Hsieh MH; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.; Institute of Biomedical Sciences, National Sun Yat-Sen University, Kaohsiung, Taiwan.
Tsai YS; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Ko YM; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Lin CC; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Chen KY; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.
Dai CY; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.; School of Medicine and Hepatitis Research Center, College of Medicine, and Center for Liquid Biopsy and Cohort Research and Center for Cancer Research, Kaohsiung Medical University, Kaohsiung, Taiwan.
Lin ZY; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.; School of Medicine and Hepatitis Research Center, College of Medicine, and Center for Liquid Biopsy and Cohort Research and Center for Cancer Research, Kaohsiung Medical University, Kaohsiung, Taiwan.
Chen SC; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.; Department of Internal Medicine, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.; School of Medicine and Hepatitis Research Center, College of Medicine, and Center for Liquid Biopsy and Cohort Research and Center for Cancer Research, Kaohsiung Medical University, Kaohsiung, Taiwan.
Huang JF; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.; Department of Internal Medicine, Kaohsiung Municipal Ta-Tung Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.; School of Medicine and Hepatitis Research Center, College of Medicine, and Center for Liquid Biopsy and Cohort Research and Center for Cancer Research, Kaohsiung Medical University, Kaohsiung, Taiwan.
Chuang WL; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.; School of Medicine and Hepatitis Research Center, College of Medicine, and Center for Liquid Biopsy and Cohort Research and Center for Cancer Research, Kaohsiung Medical University, Kaohsiung, Taiwan.
Huang CF; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.; School of Medicine and Hepatitis Research Center, College of Medicine, and Center for Liquid Biopsy and Cohort Research and Center for Cancer Research, Kaohsiung Medical University, Kaohsiung, Taiwan.; Institute of Biomedical Sciences, National Sun Yat-Sen University, Kaohsiung, Taiwan.
Yu ML; Hepatobiliary Division, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan.; School of Medicine and Hepatitis Research Center, College of Medicine, and Center for Liquid Biopsy and Cohort Research and Center for Cancer Research, Kaohsiung Medical University, Kaohsiung, Taiwan.; Institute of Biomedical Sciences, National Sun Yat-Sen University, Kaohsiung, Taiwan.; National Pingtung University of Science and Technology, Pingtung, Taiwan.
Pokaż więcej
Źródło:
Cancer medicine [Cancer Med] 2022 Jan; Vol. 11 (1), pp. 104-116. Date of Electronic Publication: 2021 Nov 16.
Typ publikacji:
Journal Article
MeSH Terms:
Salvage Therapy*
Antineoplastic Agents/*therapeutic use
Carcinoma, Hepatocellular/*drug therapy
Liver Neoplasms/*drug therapy
Phenylurea Compounds/*therapeutic use
Pyridines/*therapeutic use
Sorafenib/*therapeutic use
alpha-Fetoproteins/*metabolism
Adult ; Aged ; Aged, 80 and over ; Antineoplastic Agents/adverse effects ; Carcinoma, Hepatocellular/blood ; Disease Progression ; Female ; Humans ; Liver Neoplasms/blood ; Male ; Middle Aged ; Phenylurea Compounds/adverse effects ; Pyridines/adverse effects ; Risk Factors ; Survival Analysis ; Taiwan
Czasopismo naukowe
Tytuł:
Comparative Effectiveness Analyses of Salvage Prostatectomy and Salvage Radiotherapy Outcomes Following Focal or Whole-Gland Ablative Therapy (High-Intensity Focused Ultrasound, Cryotherapy or Electroporation) for Localised Prostate Cancer.
Autorzy:
Nathan A; University College London, London, UK; University College London Hospitals NHS Trust, London, UK; The Royal College of Surgeons of England, London, UK. Electronic address: .
Ng A; University College London, London, UK.
Mitra A; University College London Hospitals NHS Trust, London, UK.
Sooriakumaran P; University College London Hospitals NHS Trust, London, UK; Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK.
Davda R; University College London Hospitals NHS Trust, London, UK.
Patel S; University College London, London, UK.
Fricker M; Newcastle University, Newcastle, UK.
Kelly J; University College London, London, UK; University College London Hospitals NHS Trust, London, UK.
Shaw G; University College London, London, UK; University College London Hospitals NHS Trust, London, UK.
Rajan P; University College London Hospitals NHS Trust, London, UK.
Sridhar A; University College London, London, UK; University College London Hospitals NHS Trust, London, UK.
Nathan S; University College London, London, UK; University College London Hospitals NHS Trust, London, UK.
Payne H; University College London, London, UK; University College London Hospitals NHS Trust, London, UK.
Pokaż więcej
Źródło:
Clinical oncology (Royal College of Radiologists (Great Britain)) [Clin Oncol (R Coll Radiol)] 2022 Jan; Vol. 34 (1), pp. e69-e78. Date of Electronic Publication: 2021 Nov 03.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Prostatic Neoplasms*/radiotherapy
Prostatic Neoplasms*/surgery
Salvage Therapy*
Cryotherapy ; Electroporation ; Humans ; Male ; Neoplasm Recurrence, Local/radiotherapy ; Neoplasm Recurrence, Local/surgery ; Prostate-Specific Antigen ; Prostatectomy ; Retrospective Studies ; Treatment Outcome
Czasopismo naukowe
Tytuł:
BRAF, MEK, and EGFR Triplet Inhibitors as Salvage Therapy in BRAF -Mutated Metastatic Colorectal Cancer-A Case Series Study Target Therapy of BRAF- Mutated mCRC .
Autorzy:
Yeh JH; Graduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.; Division of Gastroenterology and Hepatology, Department of Internal Medicine, E-DA Dachang Hospital, Kaohsiung 80794, Taiwan.; Department of Medical technology, College of Medicine, I-Shou University, Kaohsiung 82445, Taiwan.; Division of Gastroenterology and Hepatology, Department of Internal Medicine, E-DA Hospital, Kaohsiung 82445, Taiwan.
Tsai HL; Division of Colorectal Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.; Department of Surgery, Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.
Chen YC; Division of Colorectal Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.
Li CC; Division of Colorectal Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.
Huang CW; Division of Colorectal Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.; Department of Surgery, Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.
Chang TK; Division of Colorectal Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.
Su WC; Division of Colorectal Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.
Chen PJ; Division of Colorectal Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.
Liu YP; Graduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.
Wang JY; Graduate Institute of Clinical Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.; Division of Colorectal Surgery, Department of Surgery, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.; Department of Surgery, Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.; Center for Cancer Research, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.; Center for Liquid biopsy and Cohort Research, Kaohsiung Medical University, Kaohsiung 80708, Taiwan.; Pingtung Hospital, Ministry of Health and Welfare, Pingtung 90054, Taiwan.
Pokaż więcej
Źródło:
Medicina (Kaunas, Lithuania) [Medicina (Kaunas)] 2021 Dec 07; Vol. 57 (12). Date of Electronic Publication: 2021 Dec 07.
Typ publikacji:
Journal Article
MeSH Terms:
Colorectal Neoplasms*/drug therapy
Colorectal Neoplasms*/genetics
Salvage Therapy*
Antineoplastic Combined Chemotherapy Protocols ; ErbB Receptors/antagonists & inhibitors ; Humans ; Mitogen-Activated Protein Kinase Kinases/antagonists & inhibitors ; Mutation ; Proto-Oncogene Proteins B-raf/antagonists & inhibitors
Czasopismo naukowe
Tytuł:
Relapsed/refractory acute promyelocytic leukemia with RARA-LBD region mutation was salvaged by venetoclax: A case report.
Autorzy:
Li Y; The Third Clinical Medical College, Fujian Medical University, Fuzhou, China.; Department of Hematology, Zhongshan Hospital, Xiamen University, Xiamen, China.
Yu J; Department of Hematology, Zhongshan Hospital, Xiamen University, Xiamen, China.
Xu Q; Department of Hematology, Zhongshan Hospital, Xiamen University, Xiamen, China.
Zhang K; The Third Clinical Medical College, Fujian Medical University, Fuzhou, China.; Department of Hematology, Zhongshan Hospital, Xiamen University, Xiamen, China.
Pokaż więcej
Źródło:
Medicine [Medicine (Baltimore)] 2021 Dec 03; Vol. 100 (48), pp. e28076.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Salvage Therapy*
Antineoplastic Agents/*therapeutic use
Bridged Bicyclo Compounds, Heterocyclic/*therapeutic use
Leukemia, Promyelocytic, Acute/*drug therapy
Sulfonamides/*therapeutic use
Adult ; Arsenic Trioxide/therapeutic use ; Ecchymosis ; Female ; Humans ; Leukemia, Promyelocytic, Acute/genetics ; Mutation/genetics ; Proto-Oncogene Proteins c-bcl-2/therapeutic use ; Recurrence ; Treatment Outcome ; Tretinoin/therapeutic use
Czasopismo naukowe
Tytuł:
A prospective phase II study of raltitrexed combined with S-1 as salvage treatment for patients with refractory metastatic colorectal cancer.
Autorzy:
Huang M; Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Yang Y; Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Zhu X; Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Chen Z; Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Zhang W; Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Wang C; Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Zhang X; Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Qiu L; Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Zhang Z; Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Zhao X; Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Li W; Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Wang Y; Shanxi Cancer Hospital, Taiyuan, China.
Guo W; Department of Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China.; Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China.
Pokaż więcej
Źródło:
Asia-Pacific journal of clinical oncology [Asia Pac J Clin Oncol] 2021 Dec; Vol. 17 (6), pp. 513-521. Date of Electronic Publication: 2021 Feb 10.
Typ publikacji:
Clinical Trial, Phase II; Journal Article
MeSH Terms:
Colorectal Neoplasms*/drug therapy
Salvage Therapy*
Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Camptothecin/therapeutic use ; Fluorouracil/therapeutic use ; Humans ; Leucovorin ; Prospective Studies ; Quinazolines ; Thiophenes ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Salvage Following Transoral Laser Microsurgery for Early Glottic Cancer in National Veteran Database.
Autorzy:
Voora RS; University of California, San Diego School of Medicine, La Jolla, California, U.S.A.; Division of Otolaryngology-Head and Neck Surgery, Department of Surgery, University of California-San Diego, San Diego, California, U.S.A.; Veterans Affairs San Diego Healthcare System, San Diego, California, U.S.A.
Panuganti B; Division of Otolaryngology-Head and Neck Surgery, Department of Surgery, University of California-San Diego, San Diego, California, U.S.A.; Moores Cancer Center, La Jolla, California, U.S.A.
Flagg M; University of California, San Diego School of Medicine, La Jolla, California, U.S.A.; Division of Otolaryngology-Head and Neck Surgery, Department of Surgery, University of California-San Diego, San Diego, California, U.S.A.
Kumar A; Veterans Affairs San Diego Healthcare System, San Diego, California, U.S.A.; Department of Radiation Medicine and Applied Sciences, University of California San Diego School of Medicine, La Jolla, California, U.S.A.
Qian AS; University of California, San Diego School of Medicine, La Jolla, California, U.S.A.; Department of Radiation Medicine and Applied Sciences, University of California San Diego School of Medicine, La Jolla, California, U.S.A.
Kotha NV; University of California, San Diego School of Medicine, La Jolla, California, U.S.A.; Veterans Affairs San Diego Healthcare System, San Diego, California, U.S.A.; Department of Radiation Medicine and Applied Sciences, University of California San Diego School of Medicine, La Jolla, California, U.S.A.
Qiao EM; University of California, San Diego School of Medicine, La Jolla, California, U.S.A.; Veterans Affairs San Diego Healthcare System, San Diego, California, U.S.A.; Department of Radiation Medicine and Applied Sciences, University of California San Diego School of Medicine, La Jolla, California, U.S.A.
Weissbrod PA; Division of Otolaryngology-Head and Neck Surgery, Department of Surgery, University of California-San Diego, San Diego, California, U.S.A.; Moores Cancer Center, La Jolla, California, U.S.A.
Rose B; Veterans Affairs San Diego Healthcare System, San Diego, California, U.S.A.; Moores Cancer Center, La Jolla, California, U.S.A.; Department of Radiation Medicine and Applied Sciences, University of California San Diego School of Medicine, La Jolla, California, U.S.A.
Orosco RK; Division of Otolaryngology-Head and Neck Surgery, Department of Surgery, University of California-San Diego, San Diego, California, U.S.A.; Veterans Affairs San Diego Healthcare System, San Diego, California, U.S.A.; Moores Cancer Center, La Jolla, California, U.S.A.
Pokaż więcej
Źródło:
The Laryngoscope [Laryngoscope] 2021 Dec; Vol. 131 (12), pp. 2766-2772. Date of Electronic Publication: 2021 Jul 23.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Laryngeal Neoplasms/*surgery
Natural Orifice Endoscopic Surgery/*adverse effects
Neoplasm Recurrence, Local/*therapy
Salvage Therapy/*statistics & numerical data
Squamous Cell Carcinoma of Head and Neck/*surgery
Aged ; Aged, 80 and over ; Chemoradiotherapy, Adjuvant/statistics & numerical data ; Databases, Factual/statistics & numerical data ; Female ; Glottis/pathology ; Humans ; Laryngeal Neoplasms/diagnosis ; Laryngeal Neoplasms/mortality ; Male ; Microsurgery/adverse effects ; Microsurgery/methods ; Middle Aged ; Natural Orifice Endoscopic Surgery/methods ; Neoplasm Recurrence, Local/epidemiology ; Neoplasm Staging ; Radiotherapy, Adjuvant/statistics & numerical data ; Retrospective Studies ; Salvage Therapy/methods ; Squamous Cell Carcinoma of Head and Neck/diagnosis ; Squamous Cell Carcinoma of Head and Neck/mortality ; United States/epidemiology ; United States Department of Veterans Affairs/statistics & numerical data
Czasopismo naukowe
Tytuł:
Factors associated with the clinical outcome of patients with relapsed/refractory CD19 acute lymphoblastic leukemia treated with ARI-0001 CART19-cell therapy.
Autorzy:
Ortiz-Maldonado V; Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.
Rives S; Department of Pediatric Hematology and Oncology, Hospital Sant Joan de Déu, Barcelona, Spain.; Institut de Recerca Pediàtrica Sant Joan de Déu, Barcelona, Spain.
Español-Rego M; Department of Immunology, Hospital Clínic de Barcelona, Barcelona, Spain.
Alonso-Saladrigues A; Department of Pediatric Hematology and Oncology, Hospital Sant Joan de Déu, Barcelona, Spain.
Montoro M; Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain.
Magnano L; Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.
Giné E; Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain.
Pascal M; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.; Department of Immunology, Hospital Clínic de Barcelona, Barcelona, Spain.
Díaz-Beyá M; Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.
Castella M; Banc de Sang i Teixits, Barcelona, Spain.
Català A; Department of Pediatric Hematology and Oncology, Hospital Sant Joan de Déu, Barcelona, Spain.; Institut de Recerca Pediàtrica Sant Joan de Déu, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras, Madrid, Spain.
Faura A; Department of Pediatric Hematology and Oncology, Hospital Sant Joan de Déu, Barcelona, Spain.
Rodríguez-Lobato LG; Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.
Oliver-Caldes A; Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.
Martínez-Roca A; Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain.
Rovira M; Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.
González-Navarro EA; Department of Immunology, Hospital Clínic de Barcelona, Barcelona, Spain.
Ortega JR; Department of Immunology, Hospital Clínic de Barcelona, Barcelona, Spain.
Cid J; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.; Apheresis & Cell Therapy Unit, Hospital Clínic de Barcelona, Barcelona, Spain.
Lozano M; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.; Apheresis & Cell Therapy Unit, Hospital Clínic de Barcelona, Barcelona, Spain.; Department of Medicine, University of Barcelona, Barcelona, Spain.
Garcia-Rey E; Banc de Sang i Teixits, Barcelona, Spain.
Fernández S; Medical Intensive Care Unit, Hospital Clínic de Barcelona, Barcelona, Spain.
Castro P; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.; Department of Medicine, University of Barcelona, Barcelona, Spain.; Medical Intensive Care Unit, Hospital Clínic de Barcelona, Barcelona, Spain.
Jordan I; Institut de Recerca Pediàtrica Sant Joan de Déu, Barcelona, Spain.; Department of Medicine, University of Barcelona, Barcelona, Spain.; Pediatric Intensive Care Unit, Hospital Sant Joan de Déu, Barcelona, Spain.
Villamor N; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain.; Hematopathology Unit, Hospital Clínic de Barcelona, Barcelona, Spain.
Aymerich M; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.; Hematopathology Unit, Hospital Clínic de Barcelona, Barcelona, Spain.
Torrebadell M; Institut de Recerca Pediàtrica Sant Joan de Déu, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Raras, Madrid, Spain.; Laboratory of Hematology, Hospital Sant Joan de Déu, Barcelona, Spain.
Deyà À; Clinical Immunology and Primary Immunodeficiencies Unit, Hospital Sant Joan de Déu, Barcelona, Spain.
Fernández de Larrea C; Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.; Department of Medicine, University of Barcelona, Barcelona, Spain.
Benitez-Ribas D; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.; Department of Immunology, Hospital Clínic de Barcelona, Barcelona, Spain.
Trias E; Advanced Therapies Unit, Hospital Clínic de Barcelona, Barcelona, Spain.
Varea S; Department of Clinical Pharmacology, Hospital Clínic de Barcelona, Barcelona, Spain.
Calvo G; Advanced Therapies Unit, Hospital Clínic de Barcelona, Barcelona, Spain.; Department of Clinical Pharmacology, Hospital Clínic de Barcelona, Barcelona, Spain.
Esteve J; Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain.; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.; Department of Medicine, University of Barcelona, Barcelona, Spain.; Josep Carreras Leukemia Research Institute, Barcelona, Spain.
Urbano-Ispizua A; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.; Department of Medicine, University of Barcelona, Barcelona, Spain.; Josep Carreras Leukemia Research Institute, Barcelona, Spain.
Juan M; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain .; Department of Immunology, Hospital Clínic de Barcelona, Barcelona, Spain.; Department of Medicine, University of Barcelona, Barcelona, Spain.; Clinical Immunology Platform, Hospital Clínic-Sant Joan de Déu, Barcelona, Spain.
Delgado J; Department of Hematology, Hospital Clínic de Barcelona, Barcelona, Spain .; Institut d'Investigacions Biomèdiques August Pi i Sunyer, Barcelona, Spain.; Centro de Investigación Biomédica en Red de Cáncer, Madrid, Spain.; Department of Medicine, University of Barcelona, Barcelona, Spain.
Pokaż więcej
Źródło:
Journal for immunotherapy of cancer [J Immunother Cancer] 2021 Dec; Vol. 9 (12).
Typ publikacji:
Letter; Research Support, Non-U.S. Gov't
MeSH Terms:
Drug Resistance, Neoplasm*
Salvage Therapy*
Antigens, CD19/*immunology
Cell- and Tissue-Based Therapy/*methods
Neoplasm Recurrence, Local/*therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma/*therapy
Receptors, Antigen, T-Cell/*immunology
Adolescent ; Adult ; Aged ; Child ; Child, Preschool ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Neoplasm Recurrence, Local/immunology ; Neoplasm Recurrence, Local/pathology ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/immunology ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/pathology ; Prognosis ; Survival Rate ; Young Adult
Raport
Tytuł:
Salvage Robotic-assisted Laparoscopic Radical Prostatectomy Following Focal High-Intensity Focused Ultrasound for ISUP 2/3 Cancer.
Autorzy:
Spitznagel T; Department of Urology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Hardenberg JV; Department of Urology and Urosurgery, University Medical Centre Mannheim, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
Schmid FA; Department of Urology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Rupp NJ; Institute of Pathology and Molecular Pathology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Westhoff N; Department of Urology and Urosurgery, University Medical Centre Mannheim, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
Worst TS; Department of Urology and Urosurgery, University Medical Centre Mannheim, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
Weis CA; Institute of Pathology, University Medical Centre Mannheim, Medical Faculty Mannheim, University of Heidelberg, Mannheim, Germany.
Mortezavi A; Department of Urology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.
Eberli D; Department of Urology, University Hospital Zurich, University of Zurich, Zurich, Switzerland. Electronic address: .
Pokaż więcej
Źródło:
Urology [Urology] 2021 Oct; Vol. 156, pp. 147-153. Date of Electronic Publication: 2021 Jun 27.
Typ publikacji:
Clinical Trial; Journal Article
MeSH Terms:
Erectile Dysfunction*/diagnosis
Erectile Dysfunction*/etiology
Postoperative Complications*/etiology
Postoperative Complications*/therapy
Prostatectomy*/adverse effects
Prostatectomy*/methods
Prostatic Neoplasms*/blood
Prostatic Neoplasms*/pathology
Prostatic Neoplasms*/physiopathology
Prostatic Neoplasms*/therapy
Robotic Surgical Procedures*/adverse effects
Robotic Surgical Procedures*/methods
Salvage Therapy*/adverse effects
Salvage Therapy*/methods
Urinary Incontinence*/diagnosis
Urinary Incontinence*/etiology
Extracorporeal Shockwave Therapy/*methods
Blood Loss, Surgical/statistics & numerical data ; Combined Modality Therapy/methods ; Comparative Effectiveness Research ; Humans ; Male ; Middle Aged ; Neoplasm Staging ; Outcome and Process Assessment, Health Care ; Prostate-Specific Antigen/analysis
Czasopismo naukowe
Tytuł:
A Systematic Review and Meta-analysis of Local Salvage Therapies After Radiotherapy for Prostate Cancer (MASTER).
Autorzy:
Valle LF; Department of Radiation Oncology, University of California, Los Angeles, CA, USA.
Lehrer EJ; Department of Radiation Oncology, Icahn School of Medicine at Mount Sinai, New York City, NY, USA.
Markovic D; Department of Medicine, Statistics Core, University of California, Los Angeles, CA, USA.
Elashoff D; Department of Medicine, Statistics Core, University of California, Los Angeles, CA, USA.
Levin-Epstein R; Department of Radiation Oncology, University of California, Los Angeles, CA, USA.
Karnes RJ; Department of Urology, Mayo Clinic, Rochester, MN, USA.
Reiter RE; Department of Urology, University of California, Los Angeles, CA, USA.
Rettig M; Division of Hematology and Oncology, David Geffen School of Medicine, University of California, Los Angeles, CA, USA; Division of Hematology and Oncology, VA Greater Los Angeles Healthcare System, Los Angeles, CA, USA.
Calais J; Ahmanson Translational Theranostics Division, Department of Molecular & Medical Pharmacology, University of California, Los Angeles, CA, USA.
Nickols NG; Department of Radiation Oncology, University of California, Los Angeles, CA, USA; Department of Radiation Oncology, Veteran Affairs Greater Los Angeles Healthcare System, Los Angeles, CA, USA.
Dess RT; Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA.
Spratt DE; Department of Radiation Oncology, University of Michigan, Ann Arbor, MI, USA.
Steinberg ML; Department of Radiation Oncology, University of California, Los Angeles, CA, USA.
Nguyen PL; Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Davis BJ; Department of Radiation Oncology, Mayo Clinic, Rochester, MN, USA.
Zaorsky NG; Department of Radiation Oncology, Penn State Cancer Institute, Hershey, PA, USA.
Kishan AU; Department of Radiation Oncology, University of California, Los Angeles, CA, USA; Department of Urology, University of California, Los Angeles, CA, USA. Electronic address: .
Pokaż więcej
Źródło:
European urology [Eur Urol] 2021 Sep; Vol. 80 (3), pp. 280-292. Date of Electronic Publication: 2020 Dec 11.
Typ publikacji:
Journal Article; Meta-Analysis; Research Support, Non-U.S. Gov't; Review; Systematic Review
MeSH Terms:
Neoplasm Recurrence, Local*/radiotherapy
Neoplasm Recurrence, Local*/therapy
Prostatic Neoplasms*/radiotherapy
Prostatic Neoplasms*/therapy
Salvage Therapy*/methods
Brachytherapy/adverse effects ; Brachytherapy/methods ; Cryotherapy/adverse effects ; High-Intensity Focused Ultrasound Ablation/adverse effects ; Humans ; Male ; Prospective Studies ; Prostatectomy/adverse effects ; Radiation Dosage ; Radiosurgery/adverse effects
Czasopismo naukowe
Tytuł:
Post-Transplant Nivolumab Plus Unselected Autologous Lymphocytes in Refractory Hodgkin Lymphoma: A Feasible and Promising Salvage Therapy Associated With Expansion and Maturation of NK Cells.
Autorzy:
Guolo F; Department of Oncology and Hematology (DIPOE), IRCCS Ospedale Policlinico San Martino, Genoa, Italy.; Clinic of Hematology, Department of Internal Medicine (DiMI), University of Genoa, Genoa, Italy.
Minetto P; Department of Oncology and Hematology (DIPOE), IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Pesce S; Department of Experimental Medicine (DIMES), University of Genoa, Genoa, Italy.
Ballerini F; Department of Oncology and Hematology (DIPOE), IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Clavio M; Department of Oncology and Hematology (DIPOE), IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Cea M; Department of Oncology and Hematology (DIPOE), IRCCS Ospedale Policlinico San Martino, Genoa, Italy.; Clinic of Hematology, Department of Internal Medicine (DiMI), University of Genoa, Genoa, Italy.
Frello M; Clinic of Hematology, Department of Internal Medicine (DiMI), University of Genoa, Genoa, Italy.
Garibotto M; Clinic of Hematology, Department of Internal Medicine (DiMI), University of Genoa, Genoa, Italy.
Greppi M; Department of Experimental Medicine (DIMES), University of Genoa, Genoa, Italy.
Bozzo M; Department of Experimental Medicine (DIMES), University of Genoa, Genoa, Italy.; Department of Earth, Environment and Life Sciences (DISTAV), University of Genoa, Genoa, Italy.
Miglino M; Department of Oncology and Hematology (DIPOE), IRCCS Ospedale Policlinico San Martino, Genoa, Italy.; Clinic of Hematology, Department of Internal Medicine (DiMI), University of Genoa, Genoa, Italy.
Passannante M; Clinic of Hematology, Department of Internal Medicine (DiMI), University of Genoa, Genoa, Italy.
Marcolin R; Clinic of Hematology, Department of Internal Medicine (DiMI), University of Genoa, Genoa, Italy.
Tedone E; PathologIcal Anatomy and Histology, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Colombo N; PathologIcal Anatomy and Histology, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Mangerini R; PathologIcal Anatomy and Histology, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Bo A; Stem Cell Processing Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Ruzzenenti MR; Blood Transfusion Service and Hematology, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Carlier P; Blood Transfusion Service and Hematology, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Serio A; Stem Cell Processing Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Luchetti S; Stem Cell Processing Unit, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Dominietto A; Department of Oncology and Hematology (DIPOE), IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Varaldo R; Department of Oncology and Hematology (DIPOE), IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Candiani S; Department of Earth, Environment and Life Sciences (DISTAV), University of Genoa, Genoa, Italy.
Agostini V; Blood Transfusion Service and Hematology, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Ravetti JL; PathologIcal Anatomy and Histology, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
Del Zotto G; Core Facilities, Area Aggregazione Sevizi e Laboratori Diagnostici, IRCCS Giannina Gaslini, Genoa, Italy.
Marcenaro E; Department of Experimental Medicine (DIMES), University of Genoa, Genoa, Italy.
Lemoli RM; Department of Oncology and Hematology (DIPOE), IRCCS Ospedale Policlinico San Martino, Genoa, Italy.; Clinic of Hematology, Department of Internal Medicine (DiMI), University of Genoa, Genoa, Italy.
Pokaż więcej
Źródło:
Frontiers in immunology [Front Immunol] 2021 Nov 05; Vol. 12, pp. 753890. Date of Electronic Publication: 2021 Nov 05 (Print Publication: 2021).
Typ publikacji:
Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Adoptive Transfer*
Hematopoietic Stem Cell Transplantation*
Lymphocyte Transfusion*
Salvage Therapy*
Hodgkin Disease/*therapy
Immune Checkpoint Inhibitors/*therapeutic use
Killer Cells, Natural/*immunology
Adolescent ; Adult ; Aged ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Cell Differentiation ; Cytomegalovirus Infections/complications ; Disease-Free Survival ; Feasibility Studies ; Female ; Hodgkin Disease/complications ; Hodgkin Disease/drug therapy ; Humans ; Male ; Middle Aged ; Nivolumab/therapeutic use ; Recurrence ; Transplantation, Autologous ; Young Adult
Czasopismo naukowe
Tytuł:
The Current and Future Role of Radiation Therapy in the Era of CAR T-cell Salvage.
Autorzy:
DeSelm C; Washington University School of Medicine in St Louis, St Louis, Missouri.
Pokaż więcej
Źródło:
The British journal of radiology [Br J Radiol] 2021 Nov 01; Vol. 94 (1127), pp. 20210098. Date of Electronic Publication: 2021 Aug 10.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Drug Resistance, Neoplasm*
Lymphoma, Non-Hodgkin/*radiotherapy
Neoplasm Recurrence, Local/*radiotherapy
Receptors, Chimeric Antigen/*therapeutic use
Salvage Therapy/*methods
Lymphoma, Non-Hodgkin/immunology ; Neoplasm Recurrence, Local/immunology ; Receptors, Chimeric Antigen/immunology ; Recurrence ; Salvage Therapy/trends
Czasopismo naukowe
Tytuł:
Surgical salvage of recurrent nasopharyngeal cancer- a multi-institutional review.
Autorzy:
See A; Department of Otorhinolaryngology-Head and Neck Surgery, Singapore General Hospital, Singapore; Surgery Academic Clinical Program, Duke-NUS Medical School, Singapore.
Chu C; Department of Otorhinolaryngology-Head and Neck Surgery, Singapore General Hospital, Singapore.
Kiong KL; Department of Otorhinolaryngology-Head and Neck Surgery, Singapore General Hospital, Singapore; Surgery Academic Clinical Program, Duke-NUS Medical School, Singapore.
Teo C; Department of Otorhinolaryngology-Head and Neck Surgery, Singapore General Hospital, Singapore; Surgery Academic Clinical Program, Duke-NUS Medical School, Singapore.
Tan HK; Surgery Academic Clinical Program, Duke-NUS Medical School, Singapore; Division of Surgery and Surgical Oncology, National Cancer Centre Singapore, Singapore.
Wong EWY; Department of Otorhinolaryngology, Head and Neck Surgery, The Chinese University of Hong Kong, NT East, Hong Kong.
Chan JYK; Department of Otorhinolaryngology, Head and Neck Surgery, The Chinese University of Hong Kong, NT East, Hong Kong.
Tsang RKY; Division of Otolaryngology, Department of Surgery, University of Hong Kong, Hong Kong.
Chan J; Division of Otolaryngology, Department of Surgery, University of Hong Kong, Hong Kong.
Chang KP; Department of Otolaryngology-Head and Neck Surgery, Chang Gung Memorial Hospital, Taoyuan, Taiwan.
Chien CY; Department of Otolaryngology-Head and Neck Surgery, Chang Gung Memorial Hospital, Kaohsiung, Taiwan.
Hao SP; Department of Otolaryngology-Head and Neck Surgery, Shin Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan.
Chen M; Department of Nasopharyngeal Carcinoma, Sun Yat-sen University Cancer Center, Guangzhou, China.
Lim CM; Department of Otorhinolaryngology-Head and Neck Surgery, Singapore General Hospital, Singapore; Surgery Academic Clinical Program, Duke-NUS Medical School, Singapore. Electronic address: .
Pokaż więcej
Źródło:
Oral oncology [Oral Oncol] 2021 Nov; Vol. 122, pp. 105556. Date of Electronic Publication: 2021 Oct 20.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Nasopharyngeal Neoplasms*/surgery
Salvage Therapy*
Humans ; Multicenter Studies as Topic ; Neoplasm Recurrence, Local/surgery ; Retrospective Studies
Czasopismo naukowe
Tytuł:
ADAPT First-Line Strategy for MCA Mainstem Occlusion; Analysis for Optimal Salvage Therapy and its Related Factor.
Autorzy:
Kurisu K; Department of Neurosurgery, Asahikawa Red Cross Hospital, Hokkaido, Japan. Electronic address: .
Sakurai J; Department of Neurosurgery, Asahikawa Red Cross Hospital, Hokkaido, Japan. Electronic address: .
Wada H; Department of Neurosurgery, Asahikawa Red Cross Hospital, Hokkaido, Japan. Electronic address: .
Takebayashi S; Department of Neurosurgery, Asahikawa Red Cross Hospital, Hokkaido, Japan. Electronic address: .
Kobayashi T; Department of Neurosurgery, Asahikawa Red Cross Hospital, Hokkaido, Japan. Electronic address: .
Kobayshi R; Department of Neurosurgery, Asahikawa Red Cross Hospital, Hokkaido, Japan. Electronic address: .
Gotoh S; Department of Neurosurgery, Asahikawa Red Cross Hospital, Hokkaido, Japan. Electronic address: .
Onodera K; Department of Neurosurgery, Asahikawa Red Cross Hospital, Hokkaido, Japan. Electronic address: .
Takizawa K; Department of Neurosurgery, Asahikawa Red Cross Hospital, Hokkaido, Japan. Electronic address: .
Pokaż więcej
Źródło:
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association [J Stroke Cerebrovasc Dis] 2021 Nov; Vol. 30 (11), pp. 106070. Date of Electronic Publication: 2021 Aug 27.
Typ publikacji:
Journal Article
MeSH Terms:
Infarction, Middle Cerebral Artery*/therapy
Mechanical Thrombolysis*/methods
Salvage Therapy*
Humans ; Retrospective Studies ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Inotuzumab ozogamicin and donor lymphocyte infusion is a safe and promising combination in relapsed acute lymphoblastic leukemia after allogeneic stem cell transplant.
Autorzy:
Papayannidis C; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli', Bologna, Italy.
Sartor C; Dipartimento di Medicina Specialistica Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy.
Dominietto A; Ematologia e Centro Trapianti, IRCCS Ospedale Policlinico San Martino, Genova, Italy.
Zappone E; Haematology Unit, Policlinico Le Scotte, AOUS, Siena, Italy.
Arpinati M; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli', Bologna, Italy.
Marconi G; Dipartimento di Medicina Specialistica Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy.; Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) IRCCS, Meldola, FC, Italy.
Cristiano G; Dipartimento di Medicina Specialistica Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy.
Nanni J; Dipartimento di Medicina Specialistica Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy.
Parisi S; Dipartimento di Medicina Specialistica Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy.
Barbato F; Dipartimento di Medicina Specialistica Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy.
Paolini S; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli', Bologna, Italy.
Soverini S; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli', Bologna, Italy.; Dipartimento di Medicina Specialistica Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy.
Terragna C; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli', Bologna, Italy.
Robustelli V; Dipartimento di Medicina Specialistica Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy.
Testoni N; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli', Bologna, Italy.; Dipartimento di Medicina Specialistica Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy.
Chirumbolo G; Dipartimento di Medicina Specialistica Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy.
Curti A; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli', Bologna, Italy.
Cavo M; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli', Bologna, Italy.; Dipartimento di Medicina Specialistica Diagnostica e Sperimentale, Università di Bologna, Bologna, Italy.
Bonifazi F; IRCCS Azienda Ospedaliero-Universitaria di Bologna, Istituto di Ematologia 'Seràgnoli', Bologna, Italy.
Pokaż więcej
Źródło:
Hematological oncology [Hematol Oncol] 2021 Oct; Vol. 39 (4), pp. 580-583. Date of Electronic Publication: 2021 May 07.
Typ publikacji:
Letter
MeSH Terms:
Salvage Therapy*
Inotuzumab Ozogamicin/*therapeutic use
Lymphocyte Transfusion/*methods
Neoplasm Recurrence, Local/*therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma/*therapy
Stem Cell Transplantation/*methods
Adolescent ; Adult ; Antineoplastic Agents, Immunological/therapeutic use ; Combined Modality Therapy ; Female ; Follow-Up Studies ; Humans ; Male ; Middle Aged ; Neoplasm Recurrence, Local/pathology ; Precursor Cell Lymphoblastic Leukemia-Lymphoma/pathology ; Prognosis ; Retrospective Studies ; Survival Rate ; Young Adult
Opinia redakcyjna
Tytuł:
Successful Salvage Haploidentical Bone Marrow Transplantation in a Child With Hemophagocytic Lymphohistiocytosis, When the Previously Matched Unrelated Donor Tested Positive for SARS-CoV-2 on the Day of Stem Cells Collection.
Autorzy:
Liszka K; Department of Pediatric Bone Marrow Transplantation, Oncology, and Hematology, Wroclaw Medical University, Wroclaw, Poland.
Marschollek P; Department of Pediatric Bone Marrow Transplantation, Oncology, and Hematology, Wroclaw Medical University, Wroclaw, Poland.
Gul K; Department of Pediatric Bone Marrow Transplantation, Oncology, and Hematology, Wroclaw Medical University, Wroclaw, Poland.
Musial J; Department of Pediatric Oncohematology, Medical Faculty University of Rzeszow, Clinical Provincial Hospital No. 2, Rzeszow, Poland.
Chaber R; Clinic of Pediatric Oncology and Hematology, Faculty of Medicine, University of Rzeszow, Rzeszow, Poland.
Miskiewicz-Bujna J; Department of Pediatric Bone Marrow Transplantation, Oncology, and Hematology, Wroclaw Medical University, Wroclaw, Poland.
Mlynarski W; Department of Pediatrics, Oncology and Hematology, Medical University of Lodz, Lodz, Poland.
Kalwak K; Department of Pediatric Bone Marrow Transplantation, Oncology, and Hematology, Wroclaw Medical University, Wroclaw, Poland. Electronic address: .
Pokaż więcej
Źródło:
Transplantation proceedings [Transplant Proc] 2021 Oct; Vol. 53 (8), pp. 2498-2501. Date of Electronic Publication: 2021 Apr 27.
Typ publikacji:
Case Reports; Journal Article
MeSH Terms:
Bone Marrow Transplantation*
COVID-19*/diagnosis
Epstein-Barr Virus Infections*
Hematopoietic Stem Cell Transplantation*
Lymphohistiocytosis, Hemophagocytic*/surgery
Salvage Therapy*
Child, Preschool ; Graft vs Host Disease ; Herpesvirus 4, Human ; Humans ; Male ; Stem Cells ; Transplantation Conditioning ; Unrelated Donors
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies

Prześlij opinię

Twoje opinie są dla nas bardzo ważne i mogą być niezwykle pomocne w pokazaniu nam, gdzie możemy dokonać ulepszeń. Bylibyśmy bardzo wdzięczni za poświęcenie kilku chwil na wypełnienie krótkiego formularza.

Formularz